SCHEMBL38743

SCHEMBL38743

NC(=O)c1cc2c(=O)[nH]c(Cc3cccc(Cl)c3)nc2s1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.82
PDE9A O76083 1/20 0.45
PDE1A P54750 1/20 0.45
PDE1B Q01064 1/20 0.45
PDE1C Q14123 1/20 0.45
GPR52 Q9Y2T5 1/20 0.43
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.41
ICAM1 P05362 1/20 0.41
SELE P16581 1/20 0.41
VCAM1 P19320 1/20 0.41
DYRK1A Q13627 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PNP P00491 1/20 0.40
CCNB2 O95067 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3492301 0.90 PDE5A (1.00) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL4515609 0.85 PDE5A (0.76) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL38176 0.84 PDE5A (0.73) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL37864 0.83 PDE5A (0.82) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL37776 0.82 PDE5A (0.61) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL16175587 0.82 PDE5A (0.74) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL38370 0.81 PDE5A (0.70) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL37554 0.80 PDE5A (0.66) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL38463 0.80 PDE5A (0.69) PDE5APDE9APDE1APDE1BPDE1C
SCHEMBL3494163 0.78 PDE5A (0.79) PDE5ASMN1; SMN2POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012004900-A1 THIENOPYRIMIDINE COMPOUNDS ASKA PHARMACEUTICAL CO., LTD. (JP) 2012-01-12 WO disclosed